Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, AnaptysBio Inc’s stock clocked out at $18.88, down -0.63% from its previous closing price of $19.00. In other words, the price has decreased by -$0.63 from its previous closing price. On the day, 0.55 million shares were traded. ANAB stock price reached its highest trading level at $19.11 during the session, while it also had its lowest trading level at $18.03.
Ratios:
To gain a deeper understanding of ANAB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.23 and its Current Ratio is at 10.23. In the meantime, Its Debt-to-Equity ratio is 4.35 whereas as Long-Term Debt/Eq ratio is at 4.33.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on July 22, 2024, initiated with a Buy rating and assigned the stock a target price of $55.
On July 19, 2024, JP Morgan Upgraded its rating to Overweight which previously was Neutral and also upped its target price recommendation from $29 to $69.
On April 16, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $47.Leerink Partners initiated its Outperform rating on April 16, 2024, with a $47 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 23 ’24 when Lizzul Paul F. sold 1,500 shares for $38.67 per share. The transaction valued at 58,005 led to the insider holds 15,398 shares of the business.
PAUL F LIZZUL bought 1,500 shares of ANAB for $58,005 on Sep 23 ’24. On Sep 16 ’24, another insider, LOUMEAU ERIC J, who serves as the CHIEF LEGAL OFFICER of the company, sold 8,720 shares for $39.82 each. As a result, the insider received 347,270 and left with 7,020 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANAB now has a Market Capitalization of 574493824 and an Enterprise Value of 515085952. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.47 while its Price-to-Book (P/B) ratio in mrq is 6.81. Its current Enterprise Value per Revenue stands at 9.009 whereas that against EBITDA is -3.694.
Stock Price History:
Over the past 52 weeks, ANAB has reached a high of $41.31, while it has fallen to a 52-week low of $13.36. The 50-Day Moving Average of the stock is -38.56%, while the 200-Day Moving Average is calculated to be -32.13%.
Shares Statistics:
It appears that ANAB traded 385.64K shares on average per day over the past three months and 500540 shares per day over the past ten days. A total of 26.60M shares are outstanding, with a floating share count of 25.98M. Insiders hold about 14.63% of the company’s shares, while institutions hold 98.17% stake in the company. Shares short for ANAB as of 1730332800 were 6175471 with a Short Ratio of 16.01, compared to 1727654400 on 5957554. Therefore, it implies a Short% of Shares Outstanding of 6175471 and a Short% of Float of 27.719998.
